Savara Inc. (SVRA) Stock Price

SVRAStock

$5.60+75.95%52W

Market Cap$1.15B

P/E—

PEG Ratio—

Div yield—

Beta0.19

SVRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-11.78%

Price vs S&P 500 (4W)1.26%

VGM Score39.29

Book Value / Share (Quarterly)$0.86

P/TBV (Annual)6.41x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.52

Price vs S&P 500 (YTD)-19.75%

Net Profit Margin (TTM)-4253.85%

EPS (TTM)$-0.56

10-Day Avg Trading Volume1.69M

EPS Excl Extra (TTM)$-0.56

EPS (Annual)$-0.48

ROI (Annual)-48.47%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-11537.00%

Cash / Share (Quarterly)$0.99

ROA (Last FY)-45.10%

EBITD / Share (TTM)$-0.58

ROE (5Y Avg)-47.43%

Operating Margin (TTM)-4150.00%

Cash Flow / Share (Annual)$-0.49

P/B Ratio6.16x

P/B Ratio (Quarterly)6.35x

Net Income / Employee (Annual)$-1,371,400

EV / Revenue (TTM)4134.91x

Net Interest Coverage (TTM)-345.82x

ROA (TTM)-66.42%

EPS Incl Extra (Annual)$-0.48

Current Ratio (Annual)11.85x

Quick Ratio (Quarterly)13.22x

3-Month Avg Trading Volume1.65M

52-Week Price Return75.95%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.80

P/S Ratio (Annual)4168.47x

Asset Turnover (Annual)0.00x

52-Week High$7.00

Operating Margin (5Y Avg)-11595.18%

EPS Excl Extra (Annual)$-0.48

CapEx CAGR (5Y)-63.27%

Tangible BV CAGR (5Y)29.74%

26-Week Price Return-0.54%

Quick Ratio (Annual)11.68x

13-Week Price Return9.88%

Total Debt / Equity (Annual)0.15x

Current Ratio (Quarterly)13.47x

Enterprise Value$1.08B

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)-3.49%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-19084.62%

Cash / Share (Annual)$1.15

3-Month Return Std Dev42.05%

Net Income / Employee (TTM)$-1,849,700

ROE (Last FY)-55.99%

Net Interest Coverage (Annual)-18.37x

EPS Basic Excl Extra (Annual)$-0.48

Total Debt / Equity (Quarterly)0.17x

EPS Incl Extra (TTM)$-0.56

ROI (TTM)-72.59%

P/S Ratio (TTM)4168.47x

Pretax Margin (5Y Avg)-11907.77%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.94

Price vs S&P 500 (52W)57.64%

Year-to-Date Return-7.79%

5-Day Price Return3.54%

EPS Normalized (Annual)$-0.48

ROA (5Y Avg)-35.67%

Net Profit Margin (Annual)-19084.62%

Month-to-Date Return1.83%

Cash Flow / Share (TTM)$-0.31

EBITD / Share (Annual)$-0.52

Operating Margin (Annual)-18961.54%

LT Debt / Equity (Annual)0.15x

ROI (5Y Avg)-38.10%

LT Debt / Equity (Quarterly)0.17x

EPS Basic Excl Extra (TTM)$-0.56

P/TBV (Quarterly)6.79x

P/B Ratio (Annual)6.04x

Pretax Margin (TTM)-4253.85%

Book Value / Share (Annual)$0.99

Price vs S&P 500 (13W)7.09%

Beta0.19x

Revenue / Share (TTM)$0.00

ROE (TTM)-87.19%

52-Week Low$2.98

vGradeF

mGradeB

vgmGradeD

SVRA Earnings Surprise History

Q2 25-0.14est. -0.12

Q3 25-0.14est. -0.13

Q4 25-0.13est. -0.12

Q2 26-0.16est. -0.15

SVRA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.29

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
SVRASavara Inc.	F	—	B	$5.60
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Savara Inc.

Savara Inc. is a specialty pharmaceutical company developing treatments for rare respiratory diseases. Its lead program, molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF), is in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).